Cargando…

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014–2015

The World Health Organization (WHO) Collaborating Centres for Reference and Research on Influenza (WHO CCs) tested 13,312 viruses collected by WHO recognized National Influenza Centres between May 2014 and May 2015 to determine 50% inhibitory concentration (IC(50)) data for neuraminidase inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hurt, Aeron C., Besselaar, Terry G., Daniels, Rod S., Ermetal, Burcu, Fry, Alicia, Gubareva, Larisa, Huang, Weijuan, Lackenby, Angie, Lee, Raphael T.C., Lo, Janice, Maurer-Stroh, Sebastian, Nguyen, Ha T., Pereyaslov, Dmitriy, Rebelo-de-Andrade, Helena, Siqueira, Marilda M., Takashita, Emi, Tashiro, Masato, Tilmanis, Danielle, Wang, Dayan, Zhang, Wenqing, Meijer, Adam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357725/ https://www.ncbi.nlm.nih.gov/pubmed/27265623 http://dx.doi.org/10.1016/j.antiviral.2016.06.001

Ejemplares similares

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014
por: Takashita, Emi, et al.
Publicado: (2015)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015–2016
por: Gubareva, Larisa V., et al.
Publicado: (2017)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012–2013
por: Meijer, Adam, et al.
Publicado: (2014)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016–2017
por: Lackenby, Angie, et al.
Publicado: (2018)

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020
por: Govorkova, Elena A., et al.
Publicado: (2022)

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
por: Leang, Sook-Kwan, et al.
Publicado: (2017)

Influenza antivirals currently in late‐phase clinical trial
por: Koszalka, Paulina, et al.
Publicado: (2017)

Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution
por: Farrukee, Rubaiyea, et al.
Publicado: (2022)

Characterization of neuraminidase inhibitor‐resistant influenza A(H1N1)pdm09 viruses isolated in four seasons during pandemic and post‐pandemic periods in Japan
por: Takashita, Emi, et al.
Publicado: (2013)

Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context
por: Moss, Robert, et al.
Publicado: (2016)

Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness
por: Brookes, Daniel W., et al.
Publicado: (2011)

Influenza B Viruses with Mutation in the Neuraminidase Active Site, North Carolina, USA, 2010–11
por: Sleeman, Katrina, et al.
Publicado: (2011)

Low response in eliciting neuraminidase inhibition activity of sera among recipients of a split, monovalent pandemic influenza vaccine during the 2009 pandemic
por: Ito, Hiroko, et al.
Publicado: (2020)

Estimating the Fitness Advantage Conferred by Permissive Neuraminidase Mutations in Recent Oseltamivir-Resistant A(H1N1)pdm09 Influenza Viruses
por: Butler, Jeff, et al.
Publicado: (2014)

Inhibitory effect of microalgae and cyanobacteria extracts on influenza virus replication and neuraminidase activity
por: Silva, Thauane, et al.
Publicado: (2018)

Cross-lineage protection by human antibodies binding the influenza B hemagglutinin
por: Liu, Yi, et al.
Publicado: (2019)

Mutations I117V and I117M and Oseltamivir Sensitivity of Pandemic (H1N1) 2009 Viruses
por: Hurt, Aeron C., et al.
Publicado: (2012)

A universal monoclonal antibody protects against all influenza A and B viruses by targeting a highly conserved epitope in the viral neuraminidase
por: Doyle, Tracey M, et al.
Publicado: (2014)

Antiviral Therapy for the Next Influenza Pandemic
por: Hurt, Aeron C.
Publicado: (2019)

Highly pathogenic avian influenza H7N9 viruses with reduced susceptibility to neuraminidase inhibitors showed comparable replication capacity to their sensitive counterparts
por: Tang, Jing, et al.
Publicado: (2019)

Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season
por: Okomo‐Adhiambo, Margaret, et al.
Publicado: (2013)

Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2010)

Characterization of Influenza B Virus Variants with Reduced Neuraminidase Inhibitor Susceptibility
por: Farrukee, R., et al.
Publicado: (2018)

Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem
por: Tan, Hyon-Xhi, et al.
Publicado: (2019)

Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011)

Inhibition of neuraminidase by Ganoderma triterpenoids and implications for neuraminidase inhibitor design
por: Zhu, Qinchang, et al.
Publicado: (2015)

In Vitro Characterization of Multidrug-Resistant Influenza A(H1N1)pdm09 Viruses Carrying a Dual Neuraminidase Mutation Isolated from Immunocompromised Patients
por: Takashita, Emi, et al.
Publicado: (2020)

Substitution of I222L-E119V in neuraminidase from highly pathogenic avian influenza H7N9 virus exhibited synergistic resistance effect to oseltamivir in mice
por: Tang, Jing, et al.
Publicado: (2021)

Peramivir and laninamivir susceptibility of circulating influenza A and B viruses
por: Leang, Sook-Kwan, et al.
Publicado: (2014)

A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
por: Byrne-Nash, Rose T., et al.
Publicado: (2019)

Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan
por: Chong, Yong, et al.
Publicado: (2019)

Neuraminidase B controls neuraminidase A-dependent mucus production and evasion
por: Hammond, Alexandria J., et al.
Publicado: (2021)

Assessment of the RNASound RNA Sampling Card for the Preservation of Influenza Virus RNA
por: Lau, Hilda, et al.
Publicado: (2016)

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
por: Hurt, Aeron C., et al.
Publicado: (2016)

Inhibition of Neuraminidase Inhibitor-Resistant Influenza Virus by DAS181, a Novel Sialidase Fusion Protein
por: Triana-Baltzer, Gallen B., et al.
Publicado: (2009)

Etymologia: Hemagglutinin and Neuraminidase
por: Henry, Ronnie, et al.
Publicado: (2018)

A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade
por: Oh, Ding Yuan, et al.
Publicado: (2014)

Using the Ferret as an Animal Model for Investigating Influenza Antiviral Effectiveness
por: Oh, Ding Y., et al.
Publicado: (2016)

Neutralizing Antibody Therapeutics for COVID-19
por: Hurt, Aeron C., et al.
Publicado: (2021)

Structural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B Viruses†
por: Oakley, Aaron J., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_364hlju5kdhktdirpuma45600j